Taking your company public through an IPO is a crucial step, presenting a unique opportunity to benefit both your business and its investors. Explore the Nasdaq IPO Academy, a program tailored to ...
Mills credited SailPoint's long-time CEO Mark McClain with keeping the ship steady throughout the IPO journey, calling him "a ...
AI Assets filed for a 2 million share initial public offering, and said it applied to list on the Nasdaq Capital Market. The a British Virgin Islands business company, through its Singapore subsidiary ...
The mass-affluent lender has told investors it wants to go public in New York before the end of 2027 in a move likely to be ...
3d
MarketBeat on MSNDeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI StocksDetailed price information for Pdd Holdings Inc (PDD-Q) from The Globe and Mail including charting and trades.
Some small IPOs are tentatively scheduled for the short holiday week ahead. Space and defense contractor Karman Holdings ...
A total of 90 companies are set to open their pre-listing shareholder lock-ins in various categories, testing markets' ...
Q4 2024 Earnings Call Transcript February 21, 2025 Operator: Good afternoon, everyone, and welcome to AXT’s Fourth Quarter ...
Market uncertainty stalls IPO wave as companies delay listings. Inflation, AI-driven sell-offs, and regulatory shifts raise ...
Global diagnostic company, Anbio Biotechnology (NNNN) priced its initial public offering of 1.6M shares at $5.00 per share.
Unfortunately, all that wheeling and dealing hasn't paid off as well as investors might have hoped. While Devon's stock has ...
Anbio Biotechnology NNNN IPO will take place February, 19 on the NASDAQ exchange under the ticker NNNN. The company is offering shares at an expected price between $5.00 and $6.00 per share with an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results